Anatomical faces of neuroprogression in bipolar disorder

Neuropsychiatry

Volumn 2, Issue 4, 2012, Pages 279-280

  Pfaffenseller, Bianca ^a,b   Gama, Clarissa Severino ^a,b   Kapczinski, Flavio ^a,b   Duarte, Juliana Avila ^a,c   Kunz, Mauricio ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Magnetic Resonance   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIPOLAR DISORDER; BRAIN; BRAIN ATROPHY; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FACE; HUMAN; MOOD DISORDER; NEUROANATOMY; NEUROBIOLOGY; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY;

EID: 84876511163     PISSN: 17582008     EISSN: 17582016     Source Type: Journal    
DOI: 10.2217/npy.12.35     Document Type: Article

References (12)

1. Fornito A, Mahli GS, Lagopoulos J et al. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res. 62, 123-132 (2008).
2. Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord. 10(1), 1-37 (2008).
3. Hallahan B, Newell J, Soares JC et al. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol. Psychiatry 69(4), 326-335 (2011).
4. Lisy ME, Jarvis KB, DelBello MP et al. Progressive neurostructural changes in adolescent and adult patients with bipolar disorder. Bipolar Disord. 13(4), 396-405 (2011).
5. Kapczinski F, Vieta E, Andreazza AC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 32(4), 675-692 (2008).
6. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev. 35(3), 804-817 (2011).
7. Kapczinski F, Dal-Pizzol F, Teixeira AL et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol. Psychiatry 15(8), 784-786 (2010).
8. Kapczinski F, Dal-Pizzol F, Teixeira AL et al. Peripheral biomarkers and illness activity in bipolar disorder. J. Psychiatr. Res. 45(2), 156-161 (2011).
9. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs late-stage bipolar disorder. Int. J. Neuropsychopharmacol. 12(4), 447-458 (2009).
10. Andreazza AC, Kapczinski F, Kauer-Sant'Anna M et al. 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J. Psychiatry Neurosci. 34(4), 263-271 (2009).
11. Magalhães PV, Jansen K, Pinheiro RT et al. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int. J. Neuropsychopharmacol. 19, 1-8 (2011).
12. Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol. Med. 41(2), 225-241 (2011).